{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:15Z","timestamp":1790370195009,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009007","name":"Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009007","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110251","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:21:17Z","timestamp":1788222077000},"page":"110251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attitudes of people with lived experience of hypophosphatasia (HPP) toward in-utero enzyme replacement therapy (IU-ERT) for life-threatening HPP"],"prefix":"10.1016","volume":"149","author":[{"given":"Tanvi","family":"Kaushal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Krutish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Kukurudz-Gorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Paulson","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Goodbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Rockman-Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110251_bb0005","article-title":"The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase","volume":"14","author":"Yu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2026.110251_bb0010","article-title":"Hypophosphatasia: Canadian update on diagnosis and management","volume":"30","author":"Khan","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ymgme.2026.110251_bb0015","article-title":"Diagnosis, treatment, and follow-up of patients with hypophosphatasia","volume":"87","author":"C\u00e1rdenas-Aguilera","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.ymgme.2026.110251_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-025-04129-w","article-title":"The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data","volume":"20","author":"Kishnani","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110251_bb0025","article-title":"Outcome of perinatal hypophosphatasia in manitoba mennonites: a retrospective cohort analysis","author":"Leung","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110251_bb0030","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2015-3462","article-title":"Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia","volume":"101","author":"Whyte","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110251_bb0035","series-title":"The International Conference on Children\u2019s Bone Health (ICCBH)","article-title":"Long-term survival, patient-reported outcomes, and quality-of-life in children with HPP treated with asfotase alfa starting before 2 years of age","author":"Rockman-Greenberg","year":"2026"},{"key":"10.1016\/j.ymgme.2026.110251_bb0040","author":"MacKenzie"},{"key":"10.1016\/j.ymgme.2026.110251_bb0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2200587","article-title":"In utero enzyme-replacement therapy for infantile-onset Pompe\u2019s disease","volume":"387","author":"Cohen","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110251_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13081796","article-title":"Prenatal management of spinal muscular atrophy in the era of genetic screening and emerging opportunities in in utero therapy","volume":"13","author":"Me\u017enari\u0107","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymgme.2026.110251_bb0055","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1714322","article-title":"Prenatal correction of X-linked hypohidrotic ectodermal dysplasia","volume":"378","author":"Schneider","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110251_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2023.104787","article-title":"Prenatal asfotase alfa-mediated enzyme replacement therapy restores delayed calcification in a severe infantile form of hypophosphatasia model mice","volume":"66","author":"Yoshida","year":"2023","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2026.110251_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2021.01.009","article-title":"Utility of genetic testing for prenatal presentations of hypophosphatasia","volume":"132","author":"Sperelakis-Beedham","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110251_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02178-z","article-title":"Fetal therapies and trials for lysosomal storage diseases: a survey of attitudes of parents and patients","volume":"17","author":"Schwab","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110251_bb0075","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110251_bb0080","article-title":"Enzyme replacement therapy in perinatal hypophosphatasia: case report of a negative outcome and lessons for clinical practice","volume":"14","author":"Costain","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110251_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/cen.15063","article-title":"Enzyme replacement therapy for hypophosphatasia\u2014the current paradigm","volume":"101","author":"Schindeler","year":"2024","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ymgme.2026.110251_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2021.08.014","article-title":"Parental enrollment decision-making for a neonatal clinical trial","volume":"239","author":"Weiss","year":"2021","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110251_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0869-4","article-title":"Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations","volume":"13","author":"Daniel","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110251_bb0100","author":"Canadian Agency for Drugs and Technologies in Health, CADTH Canadian Drug Expert Review Committee"},{"key":"10.1016\/j.ymgme.2026.110251_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-021-02600-8","article-title":"Regional variation in cost of neonatal intensive care for extremely preterm infants","volume":"21","author":"Rolnitsky","year":"2021","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.ymgme.2026.110251_bb0110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41372-026-02619-8","article-title":"Trends in admissions and costs for neonatal intensive care in US children\u2019s hospitals, 2017\u20132022","volume":"46","author":"Vance","year":"2026","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ymgme.2026.110251_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12325-022-02359-z","article-title":"Valuation of treatments for rare diseases: a systematic literature review of societal preference studies","volume":"40","author":"Dabbous","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ymgme.2026.110251_bb0120","series-title":"Rare Diseases: A Global Health Priority for Equity and Inclusion","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110251_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-022-05255-0","article-title":"Parental information about the option to apply for pregnancy termination after the detection of a congenital abnormality and factors influencing parental decision-making: a cohort study","volume":"22","author":"Hjort-Pedersen","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ymgme.2026.110251_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/jgc4.70099","article-title":"Evaluating pregnancy termination rates for fetal chromosome and single gene disorders","volume":"34","author":"Herman","year":"2025","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2026.110251_bb0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/bdra.23086","article-title":"Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature","volume":"94","author":"Johnson","year":"2012","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.ymgme.2026.110251_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/uog.26141","article-title":"Prenatal exome sequencing and impact on perinatal outcome: cohort study","volume":"61","author":"Poljak","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.ymgme.2026.110251_bb0145","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(18)31940-8","article-title":"Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study","volume":"393","author":"Lord","year":"2019","journal-title":"Lancet"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:37:10Z","timestamp":1790368630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1096719226005342"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110251","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitudes of people with lived experience of hypophosphatasia (HPP) toward in-utero enzyme replacement therapy (IU-ERT) for life-threatening HPP","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110251"}}